Q1 |
Was true randomization used for assignment of participants to treatment groups? |
Yes |
Q2 |
Was allocation to treatment groups concealed? |
Yes |
Q3 |
Were treatment groups similar at the baseline? |
Yes |
Q4 |
Were participants blind to treatment assignment? |
Yes |
Q5 |
Were those delivering treatment blind to treatment assignment? |
Yes |
Q6 |
Were outcomes assessors blind to treatment assignment? |
Yes |
Q7 |
Were treatment groups treated identically other than the intervention of interest? |
Yes |
Q8 |
Was follow up complete and if not, were difference between groups in terms of their follow up adequately described and analyzed? |
Yes |
Q9 |
Were participants analyzed in the groups to which they were randomized? |
Yes |
Q10 |
Were outcomes measures in the same way for treatment groups? |
Yes |
Q11 |
Were outcomes measured in a reliable way? |
Yes |
Q12 |
Was appropriate statistical analysis used? |
Yes |
Q13 |
Was the trial design appropriate, and any deviations from the standard RCT design accounted for in the conduct and analysis of the trial? |
Yes |
|
Total Score |
100% |